Empadown Duo Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
MFDS item code 202302605 · Approved 2023.09.01
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication assists adult patients with type 2 diabetes in improving blood sugar control by complementing dietary and exercise therapy, especially in patients who do not achieve adequate blood sugar control and have cardiovascular disease, caution is warranted regarding the occurrence of cardiovascular events during treatment. Thus, it is important for patients to consult with healthcare providers to ensure safe usage. This medication is used to positively impact blood sugar management and cardiovascular health.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's previous dose of metformin. If the patient tolerates empagliflozin 10 mg (total daily dose) well but requires additional glycemic control, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive the same doses of empagliflozin and metformin as before. When this medicine is co-administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as remembered. However, do not take a double dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the initial dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom the Medicine Must Not Be Used, item 2)). In patients 75 years of age or older, renal function and the risk of volume depletion should be considered.
This medication is used in diabetes treatment and consists of two ingredients that help in blood sugar control. Caution is advised when taking this medication due to the risk of rare side effects such as severe lactic acidosis, where lactic acid can accumulate in the body, leading to dangerous conditions, including potential fatality. If taken with other diabetes medications, hypoglycemia may occur, so blood sugar levels should be monitored frequently. This medication should not be administered to patients with severely impaired kidney function, acute infections, cardiovascular issues, or severe liver disease. Patients should discontinue this medication prior to surgery or any examinations using iodine contrast agents and can resume after normal kidney function is restored post-surgery. It is advisable not to use this medication in pregnant women or those who could become pregnant, and in lactating women. This medication can cause fluid loss, hence caution is necessary in cases of dehydration, diarrhea, or vomiting, with special care for elderly patients or those with cardiovascular disease. During treatment, urinary tract infections or genitourinary infections may occur, and patients should consult a doctor immediately if symptoms arise. Also, vitamin B12 levels may decrease, necessitating regular blood tests for monitoring. Avoid excessive alcohol consumption during treatment, and report any severe side effects like hypoglycemic symptoms, lactic acidosis, or ketoacidosis to healthcare providers immediately. Elderly patients are at increased risk of reduced kidney function, so regular kidney function tests are necessary, with dosage adjustments as needed. In the event of an overdose, prompt treatment is essential, especially due to the risk of lactic acidosis, and emergency care should be sought. This medication is not recommended for children, and accurate dosing and usage according to the prescribing physician must always be followed. Finally, this medication should be stored out of reach of children and kept in its original container to maintain quality.
Hypoglycemia, urinary tract infection, genital infection, increased urination, ketoacidosis, lactic acidosis, decreased vitamin B12 absorption, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, pruritus, rash, urticaria, erythema, angioedema, dysuria, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, perineal necrosis, vulvovaginitis, balanitis, loss of fluid volume, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), decreased serum vitamin B12 concentration, chronic gastritis, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, diarrhea, nausea, gastric ulcer, colitis, vomiting, ischemic colitis, colonic hemorrhage, appendiceal abscess, appendicitis, meningitis, chronic otitis media, peritonsillar abscess, pulmonary tuberculosis, sepsis, subcutaneous abscess, tubo-ovarian abscess, vestibular neuritis, headache, positional dizziness, asthenia, chest discomfort, chest pain, increased alanine aminotransferase, increased aspartate aminotransferase, weight loss, urinary stones, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, diplopia, hypertension, insomnia, anxiety, acute cholecystitis, autoimmune hepatitis, cholelithiasis, otalgia, positional vertigo, anemia, lymphadenopathy, hypothyroidism, constipation, nasopharyngitis, herpes zoster, drowsiness, fatigue, peripheral edema, facial edema, fever, facial swelling, chills, strange sensation, edema, pain, vascular stent stenosis, vascular stent thrombosis, angina, palpitations, Prinzmetal angina, coronary artery disease, atherosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral arterial occlusive disease, unstable angina
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from exposure to air and moisture, with storage temperature maintained between 1 to 30 degrees Celsius to ensure prolonged effectiveness.
Light brownish-purple, bilaterally convex, oval-shaped film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.